|
Featured Articles
|
|
Laying The Foundation For Next-Gen Cancer Diagnostics
By Kevin Davies, Thermo Fisher Scientific
While the number of targeted therapeutics and molecular tests for cancer are growing in parallel, cancer biopsies are shrinking in size. “The oncologist or pathologist has to prioritize the molecular markers. That’s a real issue,” says Foundation Medicine CEO Michael Pellini.
|
|
|
Biomanufacturing Debottlenecking And Process Optimization
By Rick Johnston, Ph.D. Founder & Principal Bioproduction Group, BIO-G
Optimizing biomanufacturing is particularly challenging because of variability and complexity associated with the sharing of finite and interdependent resources. Traditional approaches, like polling subject matter experts on the manufacturing floor or analyzing resource utilization rates, simply do not work. Worse still, the answers these approaches provide are often costly and can actually be detrimental to run rates and other critical KPIs.
|
|
|
 |
IBC's Biopharmaceutical Development & Production Week (Feb 25 to March 1, 2013) provides updates on current and emerging METHODS to improve your bioproduction capabilities and delivers strategies to help you overcome the challenges and accelerate production of the biopharma industry's most exciting new MOLECULES. Mention priority code BDP13BRO, and you can save 20% off the standard conference rates for new registrations. Check it out today at: http://bit.ly/13437Yl
|
|
|
|
Spotlight On Biomanufacturing Summit
|
|
Cell Culture
WAVE Bioreactor™ 200 and 500/1000 systems are ready-to-use products. The system is a cell culture device for the production of recombinant proteins in mammalian and insect cell lines in batch, fed-batch, and perfusion culture.
|
|
|
Introducing Disposable Systems Into Biomanufacturing
Single-use (disposable) systems are being considered and introduced into many biopharmaceutical processes because manufacturers have identified significant benefits they offer over traditional reusable systems.
|
|
|
Moving Ahead With Single-Use Technology
This paper discusses the advantages of single-use vessel, bioreactor, and mixing technologies, why they continue to grow in popularity for the bioprocessing market, and how to effectively overcome challenges in implementation of the technologies.
|
|
|
Cell Banking Application Note
The cell bank is a critical element of the manufacturing process. Procedures for creating and subsequent use of cell bank repositories are well established and have not changed significantly in years.
|
|
|
|
|
